Colorectal Cancer Clinical Trials
Participation in colorectal cancer clinical trials can provide up-to-the-minute treatment. WebMD directs you to organizations that list ongoing clinical trials.
Find out about the causes, symptoms, and treatment of follicular lymphoma, a type of cancer.
Chronic Lymphocytic Leukemia
Learn the causes, symptoms, and treatment of chronic lymphocytic leukemia, a blood cancer.
WebMD explains carcinoid syndrome, a group of symptoms you might get if you already have carcinoid tumors, a type of cancer.
Non-Small-Cell Lung Cancer
Non-small-cell lung cancer is the most common type of lung cancer. It's serious, but treatment can sometimes cure it or stop it from getting worse.
B-Cell Acute Lymphoblastic Leukemia in Children
B-cell acute lymphoblastic leukemia makes your child more likely to get sick because it affects the immune system. Find out about the causes, symptoms, and treatment.
WebMD explains the causes, symptoms, and treatment of hepatocellular carcinoma, a cancer that begins in your liver.
Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Paranasal Sinus and Nasal Cavity Cancer
The majority of tumors of the paranasal sinuses present with advanced disease,and cure rates are generally poor (=50%). Squamous cell carcinoma (SCC) is the most frequent type of malignant tumor in the nose and paranasal sinuses (70%–80%). Papillomas are distinct entities that may undergo malignant degeneration. The cancers grow within the bony confines of the sinuses and are often ...
Colorectal Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Changes to This Summary (09 / 27 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.
Changes to This Summary (06 / 12 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.This summary was reformatted.Stage I and Stage II Pancreatic Cancer TreatmentAdded text about a 5-year update of the Radiation Therapy Oncology Group (RTOG)-9704 trial, which reported that patients with pancreatic head tumors had a median survival and 5-year overall survival of 20.5 months and 22% survival rate with gemcitabine, versus 17.1 months and 18% with 5-fluorouracil. Also added text about a secondary analysis of RTOG-9704 that explored the correlation of adherence to protocol-specified radiation with patient outcomes. Added text to state that the European Organization for the Research and Treatment of Cancer/U.S. Gastrointestinal Intergroup (RTOG-0848) phase III adjuvant trial evaluating the impact of chemoradiation after completion of a full course of gemcitabine with or without